Girl’s death in China reveals human cost of unregulated science
The case has prompted debate about ‘first in human’ gene-editing trials, particularly for rare but serious disorders
Tech · 1 updates
The case has prompted debate about ‘first in human’ gene-editing trials, particularly for rare but serious disorders